2022: Page 2

Video from AACR 2022: Next-gen pathology tools for cancer research
Knudsen addressed the topic of pathomics in cancer research and what that means for the field of pathology.
April 8, 2022
2022 04 10 00 08 8403 2022 04 09 Knudsen 400
AI spots patients at elevated risk for pancreatic cancer
A team of researchers from the U.S. and Denmark used electronic health record (EHR) data from the Danish National Patient Registry to train their algorithm and then tested it on electronic medical records from Mass General Brigham Health Care System in Boston. Their model proved to be highly accurate for predicting patients at high risk for pancreatic cancer on large datasets from both countries.
April 8, 2022
2020 03 12 20 41 0454 Computer Brain Circuit Ai 400
Stilla and Promega sign comarketing agreement
The companies have combined Promega's Maxwell liquid biopsy system and Stilla's naica system, a six-color multiplexing digital PCR platform. The pairing enables an optimized workflow for a wide range of applications, including liquid biopsy, sentinel pathogen testing, infectious disease assays, overall cancer research, and drug discovery, according to the vendors.
April 7, 2022
2020 04 14 22 00 7772 Business Men Handshake 400
C2i Genomics launches MRD test in Europe
The test is the first software-as-a-medical-device MRD test and will be available in countries accepting the CE Mark, according to the company. Recently, it received CE-IVD marking in the European Union, U.K., and Switzerland.
April 5, 2022
2021 01 12 23 44 3780 Blood Test Samples Lab 400
Genialis partners with OncXerna to improve targeted therapy
Genialis' ResponderID will use OncXerna's XernaTME (tumor microenvironment) panel to incorporate the pancancer tumor microenvironment classifier to investigate potentially hundreds of new use cases for personalized therapeutic selection.
April 5, 2022
2019 04 22 23 41 4967 Cancer Cell Target2 400
AACR announces 2022 cancer research award recipients
The award recognizes female researchers who have made pioneering contributions to the understanding and treatment of breast and gynecological cancer. This year's awardees include:
April 3, 2022
2019 09 20 23 44 6333 Trophy Award 400
Biodesix NGS test highlighted in study
The company said the test can assay for major variant classes, which includes actionable mutations in support of comprehensive molecular testing in lung cancer.
March 31, 2022
2020 06 18 17 24 6922 Immunoassay Analysis 400
Personalis to present at AACR annual meeting 2022
Poster topics will include the following:
March 23, 2022
2020 07 13 17 04 9926 Conference Business 400
Guardant to highlight cancer screening studies at AACR
Key presentations will include data from Guardant's multicancer screening assay, Guardant Shield.
March 9, 2022
2020 06 01 18 51 2022 Cancer Lung 400
Previous Page
Page 2 of 2